ArticleBMC cancer2018

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.

Hiroshi Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.